PDLバイオファーマのニュース一覧

TLSA: 1H:21 Financial Update

Benzinga Real-time News2021/10/11 05:42 ET

天演药业公布2021年上半年财务业绩及公司进展

美通社2021/08/26 07:45 ET

水曜日のアフターマーケットセッションで動いている12のヘルスケア株

水曜日のアフターマーケットセッション中、AIkido Pharma（NASDAQ：AIKI）の株価は8.13％上昇して、0.93ドルとなりました。クローズ時には、AIkido Pharmaの取引量は150万株に達しました。これは、その株式の79.05％に当たります。

Benzinga Real-time News2020/12/30 18:17 ET

PDL BioPharma shares are trading higher after Silver Point Capital disclosed the purchase of 1.565 million shares.

Benzinga2020/12/24 06:52 ET

PDL Biopharma 10%+ Owner Edward Mule Reported Purchase of 1,565,000 Shares @ Avg Price of $2.60/Share in Form 4 Filing on Wednesday

Benzinga Real-time News2020/12/24 05:55 ET

Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer

MarketWatch2020/12/21 19:00 ET

PDL Biopharma 10%+ Owner Edward Mule Reported Purchase of 2,090,000 Shares @ Avg Price of $2.57/Share in Form 4 Filing on Tuesday

Benzinga Real-time News2020/12/16 05:57 ET

Is PDLI A Good Stock To Buy Now?

Insider Monkey2020/12/16 00:30 ET

PDL BioPharma Enters $51.4M Capital Provision Agreement With Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement With Wellstat

Benzinga Real-time News2020/12/14 08:36 ET

12 Healthcare Stocks Moving In Wednesday's After-Market Session

Benzinga Real-time News2020/12/09 16:44 ET

PDL BioPharma indicates timeline for Nasdaq voluntarily delisting

SeekingAlpha2020/12/09 08:29 ET

BRIEF-Pdl Announces Timeline For Voluntarily Delisting From Nasdaq

Reuters2020/12/08 16:57 ET

PDL Announces Timeline for Voluntarily Delisting from Nasdaq; Sets Date For Dec. 31, 2020

Benzinga Real-time News2020/12/08 16:10 ET

PDL Announces That It Volybtarily Be Delisting From The Nasdaq On Or About December 28, 2020

Benzinga Real-time News2020/12/08 16:08 ET

PDL BioPharma Liquidation May Offer 40% Upside For Patient Investors Comfortable With Illiquidity

SeekingAlpha2020/12/04 11:45 ET

Recap: PDL BioPharma Q3 Earnings

Benzinga Real-time News2020/11/11 17:34 ET

PDL BioPharma Q3 EPS $0.04 Misses $0.06 Estimate, Sales $4.12M Miss $5.50M Estimate

Benzinga Real-time News2020/11/11 17:07 ET

PDL BioPharma 3Q Rev $4.12M >PDLI

Dow Jones Newswires2020/11/11 16:05 ET

Press Release: PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of Dissolution

Dow Jones Newswires2020/11/11 16:05 ET

2020年11月9日に予定されている収益

ベルの前に発表する企業 • ジェネラルファイナンス (ナスダック:GFN) は、売上高7742万ドルで四半期の利益が1株あたり$0.03と予測されています。 • ストラタスプロパティーズ (ナスダック:STRS) は

Benzinga Real-time News2020/11/09 05:13 ET